Skip to main content

Table 3 Accuracy and precision of analysis in the quality-control samples

From: A LC–MS/MS method with column coupling technique for simultaneous estimation of lamivudine, zidovudine, and nevirapine in human plasma

   

Intraday

Interday

Analyte

QC sample

Actual conc. (ng/ml)

Estimated conc. (ng/ml)

Accuracy (%)

% CV

Estimated conc. (ng/ml)

Accuracy (%)

% CV

Lamivudine

LLOQ

9.63

10.05

104.36

3.01

9.33

96.83

7.12

LQC

27.53

28.06

101.95

2.01

27.92

101.43

3.20

MQC

458.76

457.46

99.72

2.26

457.49

99.72

1.92

HQC

1146.90

1152.58

100.49

1.67

1157.65

100.94

2.49

Zidovudine

LLOQ

10.44

9.81

93.95

5.77

10.30

98.64

8.19

LQC

29.84

27.83

93.25

3.52

29.59

99.15

5.59

MQC

497.37

483.61

97.23

2.56

494.18

99.36

2.75

HQC

1243.43

1227.03

98.68

2.42

1244.60

100.09

3.42

Nevirapine

LLOQ

15.24

15.06

98.86

2.96

15.60

102.40

3.84

LQC

44.29

45.00

101.60

1.89

45.74

103.28

2.83

MQC

738.19

748.98

101.46

0.86

747.47

101.26

2.24

HQC

1845.48

1878.40

101.78

1.17

1864.04

101.01

2.59